Lacutamab (Anti-KIR3DL2 / CD158k)
Lacutamab (Anti-KIR3DL2 / CD158k) is a humanized monoclonal antibody against the immune receptor human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), with potential immunomodulating and antineoplastic activities. MW: 150 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2418 |
| Sku # | A2418-1mg*25 |
| Pricing | 1mg*25, $2970.00 |